Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of inhibiting T-cell mediated B-cell antibody production using anti-CD27 antibodies

Methods of inhibiting T-cell mediated B-cell antibody production using anti-CD27 antibodies

US Patent 10301392 · Granted May 28, 2019

Estimated economic value: $91,812,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

FLT3 agonist antibodies and uses thereof2025
Interferon beta antibodies and uses thereof2025
Artificial cell death polypeptide for chimeric antigen receptor and uses thereof2025
Anti-PHF-tau antibodies and uses thereof2025
Anti-IL-23 antibodies, compositions, methods and uses2024
Anti-IL-23 antibodies, compositions, methods and uses2024
Medical device for administering anti-IL-23 antibodies2024
Anti-IL-6 antibody2024
CD73 inhibitor and A2A/A2B adenosine receptor inhibitor combination therapy2024
Anti-BCMA antibody-drug conjugates and methods of use2024
Anti-CD73 antibodies and uses thereof2024
Chimeric antigen receptor system with adaptable receptor specificity2024